Supply Chain | April 17, 2026
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
Revvity is positioning its technologies as a connected engine for discovery
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
Move amid evidence of widespread reporting gaps
Scientists at the forum warned of an increasingly volatile health landscape
The campaign builds on the three-year partnership unveiled earlier this season
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The Abbreviated New Drug Application with FDA covers multiple strengths of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
Subscribe To Our Newsletter & Stay Updated
